Results per Page:
Location, location, location: where is key for CAR T-cell therapy
From the Walter lab, Translational Science and Therapeutics Division
TIME and space predict response to CAR T-cell therapy in lymphoma
From the Hirayama and Turtle labs, Clinical Research Division
Graft-versus-host disease outcomes improving for all Fred Hutch patients
From the Long-Term Follow-Up Research Group, Clinical Research Division
Repping Epstein-Barr virus: RNA vaccine protects against cancer in mice
From the McGuire lab, Vaccine and Infectious Disease Division
Mapping novel “beacons” for targeted therapy in prostate cancer
From the Haffner lab, Human Biology and Clinical Research Divisions
FBXO42 prevents mitotic calamity in glioblastoma stem-like cells
From the Paddison lab, Human Biology Division
Blood sugar control after transplant: one approach may not fit all
From the Mielcarek group, Clinical Research Division
CD27 - the key to long-term responses for CAR-T cell therapy?
From the Riddell lab, Translational Science and Therapeutics Division
HIV prevention: does 1+1 = 2?
From HIV Vaccine Trials Network and the HIV Prevention Trials Network, Vaccine and Infectious Disease Division
In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia
From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
To Ψ or not to Ψ: how PUS1 knows where to pseudouridylate mRNAs
From the Stoddard lab, Basic Sciences Division
SND1 is required for ERGonomic growth of prostate tumors
From the Vasioukhin lab, Human Biology Division